Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
Hong Kong · Delayed Price · Currency is HKD 5.92
-0.08 (-1.33%)
Sep 10, 2025, 1:35 PM HKT
HKG:9989 Market Cap
HKG:9989 has a market cap or net worth of 18.97 billion as of September 9, 2025. Its market cap has increased by 30.00% in one year.
Market Cap
18.97B
Enterprise Value
19.06B
Revenue
5.74B
Ranking
n/a
PE Ratio
42.76
Stock Price
5.92
Market Cap Chart
Since May 6, 2010, HKG:9989's market cap has decreased from 79.74B to 18.97B, a decrease of -76.21%. That is a compound annual growth rate of -8.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 18.96B | 25.90% |
| Dec 31, 2024 | 15.06B | -10.92% |
| Dec 29, 2023 | 16.91B | -12.50% |
| Dec 30, 2022 | 19.32B | -30.93% |
| Dec 31, 2021 | 27.97B | -0.50% |
| Dec 31, 2020 | 28.11B | 3.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 293.19B |
| Hansoh Pharmaceutical Group Company | 231.38B |
| JD Health International | 204.41B |
| Innovent Biologics | 172.13B |
| Sino Biopharmaceutical | 161.14B |
| WuXi Biologics | 159.07B |
| Akeso | 142.50B |
| CSPC Pharmaceutical Group | 131.25B |